β-cell function evaluation in patients with polycystic ovary syndrome using HOMA model: A comparison between obeses e nonobeses;Avaliação da função das células β pancreáticas através do modelo matemático de HOMA em portadoras de síndrome dos ovários policísticos: Comparação entre obesas e não-obesas

Revista Brasileira de Ginecologia e Obstetricia

Volumn 29, Issue 3, 2007, Pages 141-146

  Vieira, Carolina Sales ^a   Gomes, Mariana Kefalás De Oliveira ^a   Rodrigues, Paola Cândido ^a,b   Pinto, André Pera Marques ^a,c   Dos Reis, Rosana Maria ^a   Ferriani, Rui Alberto ^a   De Sá, Marcos Felipe Silva ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fellow of the National Research Council   (Brazil)

^c Instituto de Filosofia e Ciências Sociais   (Brazil)

Author keywords

Diabetes mellitus; Insulin resistance; Insulin secretion; Islets of langerhans; Obesity; Polycystic ovary syndrome physiopathology

Indexed keywords

EID: 34447136158     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0100-72032007000300005     Document Type: Article

References (25)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004; 89(6):2745-9.
2. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000; 85(7):2434-8.
3. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, Merriam GR, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific; 1992. p. 377-84.
4. Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab. 1999; 84(6):1897-9.
5. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999; 22(1):141-6.
6. Dokras A, Jagasia DH, Maifeld M, Sinkey CA, VanVoorhis BJ, Haynes WG. Obesity and insulin resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome. Fertil Steril. 2006; 86(6):1702-9.
7. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord. 2002; 26(7):883-96.
8. Barber TM, McCarthy MI, Wass JA, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf). 2006; 65(2):137-45.
9. Goodarzi MO, Erickson S, Port SC, Jennrich RI, Korenman SG. β-cell function: a key pathological determinant in polycystic ovary syndrome. J Clin Endocrinol Metab. 2005; 90(1):310-5.
10. Carmina E, Lobo RA. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril. 2004; 82(3):661-5.
11. Salehi M, Bravo-Vera R, Sheikh A, Gouller A, Poretsky L. Pathogenesis of polycystic ovary syndrome: what is the role of obesity? Metabolism. 2004; 53(3):358-76.
12. Vrbíkova J, Bendlová B, Hill M, Vanková M, Vondra K, Stárka L. Insulin Sensitivity and β-cell function in women with polycystic ovary syndrome. Diabetes Care. 2002; 25(7):1217-22.
13. DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril. 2005; 83(5):1454-60.
14. Dunaif A, Finegood DT. β-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1996; 81(3):942-7.
15. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961; 21:1440-7.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9.
17. Hahn S, Tan S, Elsenbruch S, Quadbeck B, Herrmann BL, Mann K, et al. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia. Horm Metab Res. 2005; 37(7):438-44.
18. Colilla S, Cox NJ, Ehrmann DA. Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab. 2001; 86(5):2027-31.
19. Arslanian SA, Lewy VD, Danadian K. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab. 2001; 86(1):66-71.
20. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004; 27(6):1487-95.
21. Dunaif A. Insulin resistance in women with polycystic ovary syndrome. Fertil Steril. 2006; 86 Suppl 1:S13-4.
22. Carmina E, Napoli N, Longo RA, Rini GB, Lobo RA. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol. 2006; 154(1):141-5.
23. Faloia E, Canibus P, Gatti C, Frezza F, Santangelo M, Garrapa GG, et al. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome. J Endocrinol Invest. 2004; 27(5):424-9.
24. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Barry A, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112(17):2735-52.
25. Legro RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med. 2001; 111(8):607-13.